Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

The Cancer Immunotherapy Immunoguiding Program has conducted an IFN-γ ELISPOT proficiency panel to examine the influence of serum supplementation of test media on assay performance. Sixteen European laboratories analyzed the same PBMC samples using different locally established protocols. Participan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mander, A., Gouttefangeas, C., Ottensmeier, C., Welters, M. J. P., Low, L., van der Burg, S. H., Britten, C. M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813523/
https://www.ncbi.nlm.nih.gov/pubmed/20052465
http://dx.doi.org/10.1007/s00262-009-0814-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813523/
https://www.ncbi.nlm.nih.gov/pubmed/20052465
http://dx.doi.org/10.1007/s00262-009-0814-4

Ejemplares similares